Identification of Potential Clusters of Signs and Symptoms to Prioritize Patients' Eligibility for AADCd Screening by 3-OMD Testing: An Italian Delphi Consensus.

Carlotta Spagnoli Roberta Battini Filippo Manti Duccio Maria Cordelli Andrea Pession Melissa Bellini Andrea Bordugo Gaetano Cantalupo Antonella Riva Pasquale Striano Marco Spada Francesco Porta Carlo Fusco

Published in: Behavioural neurology (2024)

. Clusters of symptoms and signs can be used to prioritize testing with 3-OMD DBS. A clinical score was rated as highly relevant for the patient's selection. The inclusion of 3-OMD dosing in newborn screening programs was advocated with high clinical priority.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
public health
prognostic factors
peritoneal dialysis
sleep quality
case report
risk assessment
clinical practice
climate change
bioinformatics analysis